AecorBio Inc.

SEC filing

Biotechnology · Menlo Park, CA

Form D on EDGAR

Amount raised$2.5Msold at filing

Total offering$2.5M

Investors in the raise20count reported to the SEC

FiledNov 12, 2025first sale Aug 16, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Bomi FramrozeExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.